BCRX
BioCryst Pharmaceuticals, Inc.
Set alert
8.47 USD -0.05 -0.59%
8.38 Day range 8.62
6.24 52-week range 11.11
- YTD
- +8.59%
- 1 year
- +16.83%
- Open
- 8.55
- Prev close
- 8.52
- Mkt cap
- 2.16B
- Vol
- 3.53M
- Avg vol
- 4.59M
- EPS
- -1.40
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 8.38
- High
- 8.62
- Forward P/E
- 10.25
- Beta
- 0.55
- Short ratio
- 4.97
- Inst. own
- 105.81%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 8.66
- 200-d avg
- 8.74
- 1y target
- 20.55
1Y chart
Closing price and volume
Compare BCRX
Chart and line up BCRX against other symbols or a saved comparison set.
- BCRX BioCryst Pharmaceuticals, Inc.
8.47
-0.05 -0.59%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | BCRX | SPY | QQQ |
|---|---|---|---|
| Last price | 8.47 | 755.72 | 690.49 |
| Change | -0.05 | -13.64 | -24.85 |
| Change % | -0.586854% | -1.77% | -3.47% |
| Open | 8.55 | 761.38 | 697.13 |
| Day high | 8.62 | 761.46 | 698.63 |
| Day low | 8.38 | 750.36 | 683.45 |
| Previous close | 8.52 | 769.36 | 715.34 |
| Volume | 3.53M | 77.70M | 85.24M |
| Average volume | 4.59M | 41.22M | 34.57M |
| Market cap | 2.16B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -1.40 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 11.11 | 779.09 | 759.66 |
| 52-week low | 6.24 | 631.97 | 558.28 |
| 1-week return | +10.72% | -0.559233% | -1.97% |
| 1-month return | +1.68% | -0.906075% | -6.66% |
| 3-month return | -8.33% | +1.89% | +1.02% |
| 6-month return | -7.53% | +5.16% | +3.41% |
| Year-to-date return | +8.59% | +10.82% | +12.40% |
| 1-year return | +16.83% | +11.16% | +10.29% |
| 2-year return | +5.74% | +32.90% | +42.71% |
| 50-day moving average | 8.66 | 767.63 | 725.41 |
| 200-day moving average | 8.74 | 728.53 | 679.17 |
| Target price | 20.55 | — | — |
| Beta | 0.548 | 0.00 | 0.00 |
| Short ratio | 4.97 | — | — |
| Institutional ownership | 105.81% | — | — |